Ready to Get Started? Contact Us


Laminate Medical Technologies

Laminate Medical Technologies was founded in 2012 to develop solutions for the most significant challenges preventing fistula use in dialysis patients.

Laminate’s flagship product, VasQTM External Support, was designed to address the high rate of primary fistula failure and repeat procedures experienced by hemodialysis patients. Primary fistula failure rates have been estimated as high as 60% with most patients requiring frequent additional procedures to make the fistula functional.¹
However, clinical results have demonstrated fistulas treated with VasQ have a significantly greater probability for success in becoming functional without the need for additional procedures.²
You can learn more about how VasQ is improving fistulas for hemodialysis patients here .

The Laminate team is an assembly of experts from around the world spanning Israel, Europe and the United States. We are excited to build on the early success of VasQ to deliver it and other innovated solutions for fistulas to the global marketplace. Learn more about our executive team below.

  1. Dember LM, et al Dialysis Access Consortium Study Group: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: A randomized controlled trial. JAMA 299: 2164–2171, 2008
  2. Karydis N, Bevis P, Beckitt T, Silverberg D, Halak M, Calder F. An Implanted Blood Vessel Support Device for Arteriovenous Fistulas: A Randomized Controlled Trial. Am J Kidney Dis. 2020 Jan;75(1):45-53


Tammy Gilon, B.Sc

CEO & Co-founder

Tammy began her career in medical devices as an engineer for Valtech (now a part of Edwards Life Science), which developed solutions for mitral valve repair. Soon after leaving Valtech she pursued her own device ideas and eventually founded Laminate Medical with Dr. Eyal Orion in 2012 to help surgeons make better functioning fistulas. She led the engineering and design efforts in the early days of the company to create VasQ, Laminate’s flagship product. Since then she has raised 10’s of millions of dollars from a diverse array of investors to build a global team that is bringing VasQ to markets around the world. She has also continued the company’s investment in new product development to improve fistula function in parallel with efforts to gain VasQ regulatory clearance in North America and Asia-Pacific.

Anthony Rodriguez, PhD

VP Market Access

Anthony brings over a decade of experience in commercializing medical devices, primarily in the vascular access market. After receiving his PhD in Bioenigineering from the University of Washington, Anthony worked as a product specialist at Gore navigating the VIABAHN™ Stent Graft through the final stages of the REVISE study, FDA clearance and initial market launch of the new dialysis access indication. He also worked at St. Jude Medical (now Abbott) to develop the launch strategy for MultiPoint Pacing for their Cardiac Resynchronization Therapy devices. He transitioned back to vascular access with TVA Medical to help gain FDA clearance and develop the market for the endovascular fistula (endoAVF) creation. He stayed on at Becton Dickinson for a year after TVA’s acquisition to help launch endoAVF into the U.S. market and train both the internal team as well as physicians on the device and new procedure. He joined Laminate to continue his work on improving vascular access for dialysis patients by bringing VasQ as well as other innovations in the company’s pipeline to market.

Binyamin Mittelman, M.Sc

VP Clinical Development

Binyamin brings 10 of experience in the medical device industry. He started his career as a Clinical Specialist at Levant Medical Technologies, supporting products from Boston Scientific® and ZOLL® in the Cardiac Rhythm Management domain. In 2015, he joined Laminate Medical Technologies as the first member of the newly established clinical team. Over the years, he transitioned through several roles and was deeply involved in developing the company’s corpus of clinical knowledge. Binyamin was appointed VP of Clinical Development to lead the clinical activities coinciding with the U.S. commercial launch of VasQ, as well as future pipeline devices. Binyamin holds a M.Sc. in Biology from Ben-Gurion University in Beer-Sheva, Israel.

Ran Agam, B.Sc

VP Operations & Engineering

Ran started his career in the medical device industry in 2010 as a Manufacturing Engineer at GE Healthcare, after 4 years in a large Telecommunications Company. In GE Healthcare, Ran led manufacturing engineering and product controllership activities for VersaMed Medical Systems (portable life-support ventilators), including distributed production facilities, NPI, design transfer, design changes, processes and tool qualifications, and information system implementation. Ran joined Laminate Medical Technologies in 2015. As VP Operations, he oversees the VasQ Engineering, In-house and Subcontractor Manufacturing, and Supply Chain Management (MRP, Procurement, and Sales Operations). Under Ran’s production management, the company’s operational capabilities have matured from prototype to serial manufacturing in support of growing utilization of VasQ globally. Ran holds Bacherlor’s degree in Industrial Engineering and an MBA.

Orit Yarden, PhD

VP Clinical & Regulatory Affairs

Orit is a veteran of the Israeli medical device industry with 25 years of experience holding senior management positions in Clinical & Regulatory and Research & Development. She has a Ph.D. and Master’s degree in Biomedical Engineering, with a Bachelor’s degree in Mechanical Engineering, all from Tel Aviv University, Israel. Orit has vast experience in designing and executing large multicenter international clinical studies as well as smaller First in Human clinical studies, both in the pre-market and post-market settings. She has extensive background of successful regulatory submissions for 510k, IDE, PMA, and CE marked medical devices in various disciplines. Being part of Laminate since the early days, Orit designed the clinical strategy and clinical protocols from the First-In-Human Study through the FDA Pivotal Study as well as achieved CE mark approval for VasQ and FDA IDE approval for the Pivotal Study.

Einav Shlomovitz, M.Sc

VP QA & Product Localization

Einav has acquired over 20 years’ experience in the medical device industry developing her expertise in Quality Assurance. She has worked with large companies, such as GE Functional Imaging, as well as several mall start-ups, namely NanoViabronix, ORSAN, Navotek, EasyLap , Vascular Graft Solutions and Perflow Medical. Einav has been working at Laminate since 2013 and is responsible for establishing and maintaining the Quality Management System according to ISO 13485, QSR(US) and MDD/MDR(EU) requirements. During her tenure, she has ensured the proper implementation of efficient quality processes throughout Laminate’s departments to meet regulatory requirements, support VasQ's rapid growth and prepare for new products coming down the pipeline.